{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-310544","form_type":"8-K","ticker":"PEPG","cik":"0001835597","company_name":"PepGen Inc.","filed_at":"2025-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.716147+00:00","generated_at":"2026-05-16T14:03:53.279447+00:00","sec_items":["8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"PepGen appoints Joseph Vittiglio as Chief Business and Legal Officer","bullets":["Joseph Vittiglio named Chief Business and Legal Officer, effective December 8, 2025.","He brings 20+ years of biotech legal, compliance, and business development experience.","Most recently served as Chief Business and Legal Officer at bluebird bio.","At bluebird, he helped launch 3 gene therapies and completed over $400M in financings.","He previously led legal and business functions at Finch Therapeutics and AMAG Pharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-310544","json":"https://secwatch.observer/filing/0001193125-25-310544.json","markdown":"https://secwatch.observer/filing/0001193125-25-310544.md","text":"https://secwatch.observer/filing/0001193125-25-310544.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835597/000119312525310544/0001193125-25-310544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835597/000119312525310544/pepg-20251208.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T14:03:53.279447+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}